Brown v. TashmanBrown v. Tashman
By
This case is before the Court on Defendants’, Hunter S. Tashman, M.D. (“Dr. Tashman”), an obstetrician and gynecologist, and his practice, Hunter Scott Tashman, M.D., P.C. (collectively “Defendants”), Plea in Bar. After the hearing and oral argument by counsel for Plaintiff and Defendants, the Court took this matter under advisement. For the reasons set forth below, Defendants’ Plea in Bar is denied.
I. Background
Ashley Brown brings this medical malpractice suit against Defendants, alleging that Dr. Tashman acted negligently in his care and treatment of Plaintiff during the course of her third pregnancy and at the conclusion of her second pregnancy. As a result of Dr. Tashman’s alleged negligence, Plaintiff claimed that she sustained physical injury and suffered emotional distress during her third pregnancy. Plaintiff further alleged that Hunter Scott Tashman, M.D., P.C., should be held liable for Dr. Tashman’s negligence, under the theory of respondeat superior. Plaintiff filed her Complaint on July 24, 2014.
On February 17, 2016, the parties appeared before this Court for a hearing on Defendants’ Plea in Bar. Defendants argued that Plaintiff filed her Complaint outside the prescribеd two-year statute of limitations for a medical malpractice action, pursuant to Va. Code § 8.01-243(A). At
II. Relevant Facts
Dr. Tashman began treating Plaintiff for obstetric and gynecological care in April 2004. Dr. Tashman treated Plaintiff throughout her first and second pregnancies. During these courses oftreatment, Dr. Tashman determined that Plaintiff had an Rh-negative blood type. The impact of Plaintiff’s negative blood type meant that her red blood cells lacked the RhD antigen that were present in individuals with a positive blood type. During Plaintiff’s second pregnancy, blood tests revealed that Plaintiff had an RhD antibody titer of 1:64, indicating that Plaintiff had Rh alloimmunization, a medical condition that caused Plaintiff’s immune system to develop antibodies to attack Rh-positive blood cells and those antibodies would likely destruct her fetus’ Rh positive blood cells, causing fetal anemia. As a result, Plaintiff became sensitized to the Rh-positive blood type of her second child, bom on May 27, 2009. Sensitization is the process where Plaintiff’s blood developed an antibody, in this case antibody D, resulting from her Rh-negative blood type interacting with the Rh-positive blood type of her fetus and eventual child.
During the hearing, Defendant presented expert testimony of Dr. Ghidini, who established that sensitization itself is not an injury, but a developed condition after Plaintiff had been exposed to the Rh-positive blood type, likely occurring during delivery of her second child. Dr. Ghidini further opined, sensitization only becomes injurious during a subsequent pregnancy where a fetus also has an Rh-positive blood type and communication of the placenta is established. Before the placenta is established, no interaction occurs between Plaintiff and the fetus; thus, the fetus remained protected from maternal immunoglobulins. Once the cellular barrier in the placenta is established, the immunoglobulins can pass from fetal circulation to maternal circulation, alerting the maternal immune system to the presence of a body with an Rh-positive blood type and, therefore, incompatibility. The maternal response to the incompatibility can cause the maternal
Dr. Tashman testified at the hearing that, between a post-partum visit in July 2009 until Plaintiff’s visit in 2011, he provided no care to Plaintiff for her Rli-negative status. During this time frame, he did provide treatment for contraceptive methods. Further, Dr. Tashman testified that, as a result of the 1:64 titer results in January 2012, he had a management plan to include: ultrasound tests, fundal height measurements, and fetal heart rate monitoring throughout the course of the pregnancy. This management plan was in addition to treating the pregnancy itself. During Plaintiff’s second pregnancy, Dr. Tashman administered one dose of RhoGAM; however, he did not administer a second RhoGAM injection after Plaintiff gave birth in 2009.
On July 26,2012, Dr. Tashman delivered Plaintiff’s third child, Christian, via cеsarean procedure at Inova Fair Oaks Hospital. Following the cesarean procedure, Dr. Tashman conducted an Apgar examination on Christian that yielded abnormal results. Additionally, Christian suffered severe respiratory distress and was transferred to the neonatal intensive care unit (“NICU”) for seven days. NICU physicians concluded that Christian suffered respiratory insufficiency, anemia, hyperbilirubinemia, thrombocytopenia, pulmonary hypertension, tricuspid regurgitation, patent fоramen ovale, and pulmonary artery branch stenosis. The NICU discharged Christian on August 2, 2012.
On July 25, 2014, Plaintiff filed this medical malpractice suit asserting that she and Christian were injured as a proximate cause of Dr. Tashman’s failure administer the second RhoGAM injection in 2009 orto treat Plaintiff for the abnormal levels of antibodies during her third pregnancy.
III. Arguments
A. Defendants’ Plea in Bar
Defendants argue that neither Nunnally nor St. George are instructive because they did not analyze the continuing treatment rule and that Plaintiff’s cause of action accrued upon her injury, in March 2012. Defendants further
Defendants assert that “[a] litigant is not allowed to ‘approbate and reprobate’.” Matthews v. Matthews,
Defendants maintain that evidence presented at the Plea in Bar hearing established that Dr. Tashman’s course of care for Plaintiff between 2009 and 2012 did not constitute either continuous or substantially uninterrupted treаtment. Dr. Tashman’s records and testimony at the hearing supported that Plaintiff’s spouse informed Dr. Tashman that they did not plan to have any more children. Furthermore, in 2011, Plaintiff sought Dr. Tashman’s treatment for contraception. Thus, all parties expected that Dr. Tashman would not render additional car.e for Plaintiff’s Rh status because this condition is only a concern during a pregnancy. Accordingly, the evidence established a cessation in treatment. See Farley,
B. Plaintiffs Opposition
As a threshold matter, Plaintiff asserts that Defendants made no mention of the continuing treatment rule in their Plea in Bar memorandum.
Plaintiff argues, alternatively, that the continuing treatment rule apрlied in 2009 at the time of Dr. Tashman’s alleged negligence. Plaintiff asserts that the continuing treatment rule stands for the proposition that, “if there existed a physician-patient relationship where the patient was treated for the same or related ailments over a continuous and uninterrupted course, then the plaintiff [can] wait until the end of that treatment to complain of any negligence which occurred during that treatment.” Grubbs v. Rawls,
A plea in bar is a defensive pleading which “shortens the litigation by reducing it to a distinct issue of fact which, if proven, creates a bar to the plaintiff’s right of recovery.” Tomlin v. McKenzie,
V. Discussion
A. Dr. Tashman''s Alleged Negligence in 2009, for Failure To Administer RhoGAM, Did Not Constitute an Injury until Plaintiff Subsequently became Pregnant and Her Fetus Sustained Injury in March 2012
Virginia Code § 8.01-243(A) provides, in pertinent part, that “every action for personal injuries, whatever the theory of recovery . . . shall be brought within two years after the cause of action accrues.” In еvery action with a prescribed statute of limitations, “the right of action shall be deemed to accrue and the prescribed limitation period shall begin to run from the date the injury is sustained in the case of injury to the person....” Va. Code § 8.01-230. It is well-established that Virginia courts construe “‘injury’ to mean positive, physical, or mental hurt to the claimant, not legal wrong to him in the broad sense that his legally protected interests have been invaded.” Locke v. Johns-Manville Corp.,
On appeal, the Virginia Supreme Court reversed the trial court, concluding that the statute of limitations did not bar the patient’s negligence claim where the actionable injury had not been the underlying canсer or alleged negligent act, but the subsequent spread and resulting injury. Id.,
The Court acknowledges the limited instruction provided in St. George as it is distinguishable from the present case for two key reasons. First, the plaintiff in St. George suffered injury as a result of a misdiagnosis. St. George,
In Nunnally, the salient facts are, on February 6, 1989, Defendant physician, Dr. Artis, performed plaintiff’s (“Nunnally”) tubal ligation procedure to prevent future pregnancies, which would be detrimental to her health. Nunnally subsequently became pregnant, and gavе birth on November 1, 1993. On October 18, 1995, Nunnally filed her motion for judgment against Dr. Artis and Danville Memorial Hospital (“the defendants”) alleging that Dr. Artis negligently performed the tubal ligation procedure. The defendants filed a plea in bar alleging that Nunnally filed her action outside of the prescribed statute of limitations. Nunnally,
[T]he injury of which Nunnally complains is not “trauma, pain, and inconvenience” that may have been associated with the negligent sterilization procedure. Rather, she complains of the consequences of the wrongful сonception and the subsequent pregnancy which, for medical reasons, she sought to avoid. Indeed, we fail to understand how a plaintiff could*270 have a cause of action for wrongful conception if there has been no conception.
Id. (citations omitted; emphasis added). Similar to the present facts, Plaintiff complained of consequences for alleged medical malpractice that occurred in 2009 and negatively impacted her subsequent pregnancy. However, Plaintiff would not have a cause of action unless she subsequently became pregnant, as occurred in Nunnally. The unrebutted expert testimony of Dr. Ghidini demonstrated that Plaintiff sustained injury within a four-week window in March 2012, between the sixteenth and twentieth weeks of pregnancy, based upon the physiology of the placental implantation. (Tr. 41-45.) Dr. Ghidini’s testimony established to a reasonable degree of medical certainty that Plaintiff could not sustain injury from the alleged negligent failure to administer RlioGAM in 2009, unless and until she became pregnant and that the actionable injury, fetal compromise for maternal Rh immunization, occurred within a four-week period in March 2012. (Tr. 41-44.) Accordingly, the statute of limitations did not accrue for the 2009 failure to administer RhoGAM until March 2012, when injury to the fetus first occurred.
B. Dr. Tashman’s Treatment of Plaintiff Throughout Her Third Pregnancy Constituted Continuing Treatment
The continuing treatment rule provides an exception to the two-year statute of limitations to bring an action under Va. Code § 8.01-243(A). Chalifoux,
[Wjhen malpractice is claimed to have occurred during a continuous and substantially uninterrupted course of examination and treatment in which a particular illness or condition should have been diagnosed in the exercise of reasonable care, the date of injury occurs, the cause of action for that malpractice accrues, and the statute of limitations commences to run when the improper course of examination, and treatment if any, for the particular malady terminates.
Justice,
Here, Dr. Tashman provided ongoing and continuous care throughout Plaintiff’s third pregnancy, beginning in 2011 until, at least, Christian’s birth on July 26, 2012. In December 2011, Dr. Tashman began providing obstetrical prenatal care during Plaintiff’s third pregnancy. (Tr. 119-120.) In January 2012, Plaintiff’s blood examination revealed an abnormal
C. Dr. Tashman Did Not Provide Continuous or Substantially Uninterrupted Care for Plaintiffs Blood Sensitization-Related Issues from 2009 through the Delivery of Plaintiff s Third Child in 2012
The continuing treatment rule is limited tо contexts of a single, continuous, and uninterrupted course of treatment. Grubbs v. Rawls,
In this case, the evidence established a cessation in treatment after the 2009 delivery of Plaintiff’s second child. At the February 17, 2016, hearing, Plaintiff’s counsel specifically stated that, “[wje’re not contending that [Plaintiff] was under [Dr. Tashman’s] continuing treatment for Rh sensitization from 2009 until 2012. We’ve nowhere contended that. . . . The continuing treatment in this case is from the date of injury.” (Tr. 117-18.) When asked by the Court whether Plaintiff contends that Dr. Tashman provided uninterrupted treatment from 2009 through her third pregnancy, Plaintiff’s counsel responded, “[n]o, never have.” (Tr. 100.) Additionally, Dr. Tashman testified that he did not provide any care related to Plaintiff’s Rh negative status between July 2009 and December 2011. (Tr. 113.) Dr. Tashman testified that he did provide carе for Plaintiff related to contraception between July 2009 and December 2011. (Tr. 113-14.) Accordingly, Dr Tashman did not provide continuous, substantially uninterrupted care for Plaintiff between July 2009 and December 2011 for blood sensitization-related issues.
For the foregoing reasons, the Court finds to a reasonable degree of medical certainty that Plaintiff sustained her actionable injury for fetal compromise for maternal Rh immunization in March 2012, and, further, that Dr. Tashman provided continuous, uninterrupted treatment for Plaintiff from the date of injury throughout the duration of her third pregnancy until, at least, July 26, 2012. Accordingly, Defendants’ Plea in Bar is denied.